Clinical Trial Update: Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies [NA]

View source ↗

Summary

A clinical trial update examining whether CDA and/or dCK metabolizing enzymes influence the response to azacitidine in patients with hematologic malignancies. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Myelodysplastic Syndromes (MDS), Leukemia Acute Myeloid - AML | NA | Status: RECRUITING